BioSpace News Archive

If you’re contemplating changing careers in the midst of the COVID-19 pandemic, the reality is that if it’s time to make a change, there’s no time like the present.

Vaxart announced new data from its Hamster Challenge Study today, showing that its oral COVID-19 vaccine candidate can potentially reduce viral load and induce a significant immune response.

In a Nov. 11 letter, 74 medical associations, including the American College of Radiology® and American Medical Association, thanked HR 8702 sponsors for introducing the legislation to halt Medicare payment cuts resulting from evaluation and management code changes to start Jan. 1, 2021.

$11.55 million invested in 98 total research investments on promising research, including COVID-19, lung cancer, vaping impact on lung health

Global developer of next-generation ultrasound solutions brings industry-leading Resona 7 Ultrasound System to largest member-driven healthcare performance improvement company in the country

CLIA-Certified Laboratory Receives FDA Emergency Use Authorization for Saliva-based Testing and Collection Device

Lumenis, Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, announced the launch of the revolutionary new Digital Duet, the first digital SLT-YAG system on the market.

Eli Lilly and Company (NYSE:LLY) will participate in the Bernstein Operational Decisions Conference on Monday, November 16, 2020 . Andrew Adams , Ph.D., vice president of new therapeutic modalities and scientific leader for Lilly’s anti-COVID-19 platform, Jeff Emmick , M.D., Ph.D., vice president of diabetes product development,

Analysis from Phase 3 ATTR-ACT and Its Long-Term Extension Study Demonstrates VYNDAQEL ® 80 mg/VYNDAMAX ® 61 mg Significantly Improved Survival in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Compared to VYNDAQEL 20 mg

IsoPlexis’ single-cell proteomics was shown to be a non-invasive and predictive biomarker of response data presented at SITC 2020 Annual Meeting for the PIVOT-02 Trial